A019170 logo

Shinpoong Pharmaceutical Co.,Ltd Stock Price

KOSE:A019170 Community·₩574.1b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A019170 Share Price Performance

₩0
-8160.00 (-100.00%)
₩0
-8160.00 (-100.00%)
Price ₩0

A019170 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet and overvalued.

1 Risk
0 Rewards

Shinpoong Pharmaceutical Co.,Ltd Key Details

₩231.9b

Revenue

₩134.9b

Cost of Revenue

₩97.0b

Gross Profit

₩100.8b

Other Expenses

-₩3.7b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-72.34
41.85%
-1.60%
18.1%
View Full Analysis

About A019170

Founded
1962
Employees
819
CEO
Jei-Man Ryu
WebsiteView website
shinpoong.co.kr

Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products, as well as antivirals, anticancer drugs, painkillers, anti-inflammatory products, and anthelmintics. It provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; and drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periarthritis, and surgical adhesion barrier; prescription drugs; wound dressings; health functional food; and over the counter products. In addition, the company engages in business management and exports its products to approximately 50 countries. The company was founded in 1962 and is headquartered in Seoul, South Korea.

Recent A019170 News & Updates

Recent updates

No updates